Related Experiment Videos
Ependymoma, glioblastoma, and acute leukemia in a child
Medical and Pediatric Oncology
|January 1, 1983
Insights
A child developed multiple rare cancers, including ependymoma, glioblastoma, and leukemia, after treatment. This suggests a potential link between cancer therapies and secondary malignancies in susceptible individuals.
Area of Science:
- Pediatric Oncology
- Cancer Genetics
- Radiation Oncology
Background:
- Ependymoma is a primary brain tumor that can occur in children.
- Cancer treatment often involves chemotherapy and radiotherapy, which carry risks of secondary malignancies.
- Genetic predisposition can influence an individual's susceptibility to developing cancer.
Observation:
- A 5-year-old boy was diagnosed with ependymoma.
- Following treatment with chemotherapy and radiotherapy, the patient developed glioblastoma multiforme and acute myeloblastic leukemia.
- The patient's maternal grandmother had a history of early-onset colon cancer.
Findings:
- The development of multiple, distinct cancers in this patient is highly unusual.
- Ependymoma is not typically associated with an increased risk of other cancers.
- The patient's cancer history suggests a potential susceptibility to malignant disease.
Implications:
- Combined cancer therapies may increase the risk of secondary malignancies in susceptible individuals.
- Further research is needed to understand the interplay between genetic factors, cancer treatments, and secondary cancer development.
- This case highlights the importance of long-term monitoring for secondary cancers in childhood cancer survivors.
Abstract:
A 5-year-old boy developed an ependymoma; 3 years later, after chemotherapy and radiotherapy, he developed glioblastoma multiforme and acute myeloblastic leukemia. His maternal grandmother had died at a young age of colon cancer. Since ependymoma is not known to predispose to other cancers, the unusual sequence of malignant disease may have been due to combined therapy in a susceptible host.